ctrl K

Price Alert

Repare Therapeutics Inc. (RPTX)

NASDAQ: RPTX · Real-Time Price · USD

1.58

0.02 (1.28%)

At close: Aug 15, 2025, 3:59 PM

1.57

-0.63%

After-hours: Aug 15, 2025, 04:04 PM EDT

Repare Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	84.72M	111.27M	159.52M	334.43M
Short-Term Investments	68.07M	112.36M	184.42M	7.44M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.14M	2.67M	497K	586K
Receivables	12.35M	15.31M	4.32M	3.23M
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a
Total Current Assets	171.15M	243.69M	353.98M	351.41M
Property-Plant & Equipment	4.22M	7.54M	9.6M	13.1M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	5.36M	10.21M	10.1M	17.3M
Total Assets	176.51M	253.9M	364.07M	368.71M
Account Payables	3.62M	2.4M	461K	2.3M
Deferred Revenue	n/a	10.22M	53.1M	11.92M
Short-Term Debt	n/a	n/a	n/a	1.72M
Other Current Liabilities	166K	17.08M	16.03M	12.03M
Total Current Liabilities	25.29M	39.08M	78.62M	35.09M
Long-Term Debt	n/a	1.01M	n/a	n/a
Other Long-Term Liabilities	n/a	-1.01M	2.68M	39.61M
Total Long-Term Liabilities	88K	2.74M	5.94M	45.2M
Total Liabilities	25.38M	41.82M	84.56M	80.29M
Total Debt	1.93M	3.41M	5.43M	7.31M
Common Stock	486.67M	483.35M	482.03M	480.7M
Retained Earnings	-417.8M	-333.11M	-239.31M	-210.27M
Comprehensive Income	54K	28K	-428K	n/a
Shareholders Equity	151.13M	212.08M	279.52M	288.42M
Total Investments	68.07M	112.36M	184.42M	7.44M